Immunohistochemical Expression and Clinicopathological Assessment of PD-1, PD-L1, NY-ESO-1, and MAGE-A4 Expression in Desmoid Tumor
Anticancer Research · 2026
DOI: 10.21873/anticanres.18037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Kazuhiko Hashimoto und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Kindai University Hospital, Sakai, Japan; hazzhiko@med.kindai.ac.jp. Hauptthemen laut MEDLINE: Programmed Cell Death 1 Receptor, B7-H1 Antigen, Desmoid Tumors, Membrane Proteins.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Kindai University Hospital, Sakai, Japan; hazzhiko@med.kindai.ac.jp.
- Department of Orthopedic Surgery, Kindai University Hospital, Sakai, Japan.
- Department of Orthopedic Surgery, Kindai Nara University Hospital, Ikoma, Japan.
Zitieren
APA
Hashimoto, K., Nishimura, S., Tan, H., Ito, T., & Goto, K. (2026). Immunohistochemical Expression and Clinicopathological Assessment of PD-1, PD-L1, NY-ESO-1, and MAGE-A4 Expression in Desmoid Tumor. Anticancer Research. https://doi.org/10.21873/anticanres.18037
Vancouver
Hashimoto K, Nishimura S, Tan H, Ito T, Goto K. Immunohistochemical Expression and Clinicopathological Assessment of PD-1, PD-L1, NY-ESO-1, and MAGE-A4 Expression in Desmoid Tumor. Anticancer Research. 2026. doi:10.21873/anticanres.18037
BibTeX
@article{Hashimoto2026,
author = {Hashimoto, Kazuhiko and Nishimura, Shunji and Tan, Hiroki and Ito, Tomohiko and Goto, Koji},
title = {Immunohistochemical Expression and Clinicopathological Assessment of PD-1, PD-L1, NY-ESO-1, and MAGE-A4 Expression in Desmoid Tumor},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.18037}
}
EUVIMED